TCL Archive NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement June 26, 1987
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive In Brief: Earl Pollack To Retire As Head Of Seer Program; Nursing Foundation, Lederle Offer Scholarships December 7, 1984